| |
 |
|
Class Information
Number: 514/423
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) > The five-membered hetero ring consists of one nitrogen and four carbons > C=x bonded directly to the five-membered hetero ring by nonionic bonding (x is chalcogen)
Description: Subject matter wherein C=X (X is chalcogen) is bonded directly to the five-membered hetero ring by nonionic bonding.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7615572 |
Pyrrole and pyrazole DAAO inhibitors |
Nov. 10, 2009 |
| 7612103 |
Pleuromutilin derivatives as antimicrobials |
Nov. 3, 2009 |
| 7612068 |
Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives |
Nov. 3, 2009 |
| 7608677 |
Method for preparing polymeric organic iridium compositions |
Oct. 27, 2009 |
| 7605177 |
Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration |
Oct. 20, 2009 |
| 7601753 |
Pyrrolidine melanocortin-specific compounds |
Oct. 13, 2009 |
| 7601752 |
Pyrrolidine derivatives |
Oct. 13, 2009 |
| 7601742 |
Pyrrolidones with anti-HIV activity |
Oct. 13, 2009 |
| 7601360 |
Excitatory amino acid inhibitors for treating sensitive skins |
Oct. 13, 2009 |
| 7592365 |
Substituted pyrroles, compositions containing same, method for making same and use thereof |
Sep. 22, 2009 |
| 7592336 |
Hepatitis C virus inhibitors |
Sep. 22, 2009 |
| 7589118 |
IAP BIR domain binding compounds |
Sep. 15, 2009 |
| 7589076 |
Substituted aryl piperidinylalkynyladenosines as A2AR agonists |
Sep. 15, 2009 |
| 7585886 |
Pyrrolidine derivative or salt thereof |
Sep. 8, 2009 |
| 7579369 |
CB 1 receptor inverse agonists |
Aug. 25, 2009 |
| 7579320 |
IAP BIR domain binding compounds |
Aug. 25, 2009 |
| 7572770 |
Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes |
Aug. 11, 2009 |
| 7560446 |
Use of angiotensin II receptor antagonists for treating acute myocardial infarction |
Jul. 14, 2009 |
| 7557136 |
Pyrrolidine derivatives as oxytocin antagonists |
Jul. 7, 2009 |
| 7550487 |
Pyrrolidine-3,4-dicarboxamide derivatives |
Jun. 23, 2009 |
| 7550453 |
2-alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof |
Jun. 23, 2009 |
| 7547724 |
IAP BIR domain binding compounds |
Jun. 16, 2009 |
| 7547722 |
Chemical compounds |
Jun. 16, 2009 |
| 7544714 |
Lipid-amino acid conjugates and methods of use |
Jun. 9, 2009 |
| 7538136 |
Crystalline forms of atorvastatin |
May. 26, 2009 |
| 7538128 |
Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing them |
May. 26, 2009 |
| 7534810 |
Salt forms of [R--(R*,R*)]-2-(4-fluorophenyl)-.beta., .delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H- -pyrrole-1-heptanoic acid |
May. 19, 2009 |
| 7524844 |
Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing them |
Apr. 28, 2009 |
| RE40667 |
[R-(R*R*)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl-3-- phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof |
Mar. 17, 2009 |
| 7504429 |
Tyrosine kinase inhibitors |
Mar. 17, 2009 |
| 7501450 |
Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
Mar. 10, 2009 |
| 7495016 |
Pyrrolidones with anti-HIV activity |
Feb. 24, 2009 |
| 7488750 |
Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
Feb. 10, 2009 |
| 7488747 |
Pyrrole and pyrazole DAAO inhibitors |
Feb. 10, 2009 |
| 7488725 |
Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase IV and methods |
Feb. 10, 2009 |
| 7485626 |
Combinations of enzyme inhibitor-containing preparations and the use thereof |
Feb. 3, 2009 |
| 7482026 |
Compositions and methods directed towards sore muscles and joints |
Jan. 27, 2009 |
| 7462641 |
(2S,4S)-4-fluoro-1-[4-fluoro-beta-(4-fluorophenyl)-L-phenylalanyl]-2-pyrro- lidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof |
Dec. 9, 2008 |
| 7459473 |
N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres |
Dec. 2, 2008 |
| 7459428 |
Method of regulating glucose metabolism, and reagents related thereto |
Dec. 2, 2008 |
| 7449479 |
Hepatitis C virus inhibitors |
Nov. 11, 2008 |
| 7446125 |
Derivatives of nitroproline compounds, processes of manufacture and uses in the treatment of integrin mediated disorders |
Nov. 4, 2008 |
| 7439257 |
Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
Oct. 21, 2008 |
| 7429613 |
Process for the preparation of atorvastatin and intermediates |
Sep. 30, 2008 |
| 7427619 |
Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
Sep. 23, 2008 |
| 7425576 |
Compounds as inhibitors of hepatitis C virus NS3 serine protease |
Sep. 16, 2008 |
| 7423058 |
Inhibitors of hepatitis C virus NS3 protease |
Sep. 9, 2008 |
| 7423057 |
Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
Sep. 9, 2008 |
| 7419998 |
Therapeutic methods and compositions involving isoflavones |
Sep. 2, 2008 |
| 7419974 |
Cyclohexyl(alkyl)propanolamines, preparation method and pharmaceutical compositions containing same |
Sep. 2, 2008 |
|
|
|
